Delfi Diagnostics News and Activities

View the org chart displaying its 20 main executives

Most searched biographies at Delfi Diagnostics

• Susan Tousi, Chief Executive Officer and Director
• Liz Homans, Chairman of the Board
• Victor Velculescu, Director

Popular executive movements at Delfi Diagnostics

• Charles Newton has joined the company as Board Member  (posted on April 28 2026).
• Cindy Soriano, who was Vice President, Finance, is promoted to Chief Financial Officer  (posted on January 9 2026).
• Tom Russo, Chief Financial Officer, has left the company  (posted on January 9 2026).

Click here to view some more movements at Delfi Diagnostics

Create your alert
to follow the executive moves at Delfi Diagnostics.

Delfi Diagnostics has 3,589 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).

Popular M&A news in Healthcare

• Cadence Solutions has just announced a $100 Million fundraising (posted on June 24 2026).
• Kardigan is now listed under ticker KARD. (posted on June 19 2026).
• Vizient has acquired Empierus (posted on June 12 2026).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Dan Rice - Board Member at Adobe Population Health
• Gregory Adams - Chief Executive Officer and Chairman of the Board at Kaiser Permanente

Learn more about the Healthcare industry

Press releases by Delfi Diagnostics

• DELFI Diagnostics Receives New York State Department of Health Clinical Laboratory Permit, Completing Authorization to Serve Health Systems Across All 50 States
• Why DELFI Diagnostics’ New York approval could shake up the lung cancer screening market - PharmaDeviceNews
• DELFI Diagnostics to Present First Clinical Utility Data for Blood-Based Lung Cancer Screening at ATS 2026 International Conference
• Delfi Diagnostics Previews Lung Cancer Data Readouts, Reimbursement Plans at JPM
• DELFI Diagnostics Appoints Charles Newton to Board of Directors
• DELFI Diagnostics to Showcase Whole-Genome cfDNA Platform Advances in Cancer Detection and Monitoring at AACR 2026 Annual Meeting
• DELFI Diagnostics to Showcase Whole-Genome cfDNA Platform Advances in Cancer Detection and Monitoring at AACR 2026 Annual Meeting
• DELFI Diagnostics Appoints Cindy Soriano as Chief Financial Officer and Announces Participation in 44th Annual J.P. Morgan Healthcare Conference
• Hackensack Meridian Health Partners with DELFI Diagnostics
• Johns Hopkins Researchers Develop Fragmentomic Test for Pancreatic Cancer Treatment Response
• View more press releases Close

Social media about Delfi Diagnostics

• Delfi Diagnostics on Wikipedia, Google News & Yahoo Finance
• Delfi Diagnostics on LinkedIn, X (Twitter) & YouTube